TAVALISSE Trademark

Trademark Overview

On Friday, August 19, 2016, a trademark application was filed for TAVALISSE with the United States Patent and Trademark Office. The USPTO has given the TAVALISSE trademark a serial number of 87144949. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, October 25, 2024. This trademark is owned by Rigel Pharmaceuticals, Inc.. The TAVALISSE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of immune system diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; anti-inflammatory pharmaceutical preparations; pharmaceutical preparations for the treatment of hematological conditions, diseases and disorders
tavalisse

General Information

Serial Number87144949
Word MarkTAVALISSE
Filing DateFriday, August 19, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, October 25, 2024
Registration Number5638421
Registration DateTuesday, December 25, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 15, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of immune system diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; anti-inflammatory pharmaceutical preparations; pharmaceutical preparations for the treatment of hematological conditions, diseases and disorders
Translation of Words in MarkThe English Translation of the word "TAVALISSE" in the mark is "ordinary".

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 24, 2016
Primary Code005
First Use Anywhere DateMonday, April 30, 2018
First Use In Commerce DateMonday, April 30, 2018

Trademark Owner History

Party NameRigel Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameRigel Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94080
Party NameRigel Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94080

Trademark Events

Event DateEvent Description
Wednesday, November 30, 2016ASSIGNED TO EXAMINER
Tuesday, August 23, 2016NEW APPLICATION ENTERED
Wednesday, August 24, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 22, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, December 5, 2016NON-FINAL ACTION WRITTEN
Monday, December 5, 2016NON-FINAL ACTION E-MAILED
Monday, December 5, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 2, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 2, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, June 3, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 2, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 22, 2017EXAMINERS AMENDMENT -WRITTEN
Thursday, June 22, 2017EXAMINERS AMENDMENT E-MAILED
Wednesday, July 26, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 26, 2018SOU EXTENSION 1 FILED
Monday, March 26, 2018SOU EXTENSION 1 GRANTED
Wednesday, March 28, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 10, 2018TEAS STATEMENT OF USE RECEIVED
Wednesday, October 10, 2018USE AMENDMENT FILED
Thursday, June 22, 2017EXAMINER'S AMENDMENT ENTERED
Tuesday, July 11, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 15, 2017PUBLISHED FOR OPPOSITION
Tuesday, August 15, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 10, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 26, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, November 6, 2018STATEMENT OF USE PROCESSING COMPLETE
Monday, May 13, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 17, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 17, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 17, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 17, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 17, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, November 5, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 20, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, November 21, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 25, 2018REGISTERED-PRINCIPAL REGISTER
Friday, February 3, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 3, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 3, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 3, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 3, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, December 25, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, May 2, 2024TEAS SECTION 8 & 15 RECEIVED
Friday, October 25, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, October 25, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, October 25, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

tavalisse pharmaceutical preparations disorders diseases treatment inflammatory conditions hematological anti system